期刊文献+

子痫前期和慢性肾病肾小球滤过率下降孕妇蛋白尿成分的差异性研究

Study on the difference on the proteinuria components between pregnant women with declined eGFR in preeclampsia and chronic kidney disease
原文传递
导出
摘要 目的 探讨子痫前期(PE)和慢性肾病(CKD)肾小球滤过率(eGFR)下降孕妇蛋白尿成分的差异。方法回顾性收集2016年7月至2022年12月328名孕妇的eGFR值和蛋白尿成分的资料进行分析。结果 当eGFR≥90mL/(min·1.73 m^(2))时,CKD组患者血清白蛋白(sAlb)高于PE组,但PE组患者24 h蛋白尿高于CKD组。而两组患者之间的尿微量白蛋白(uAlb)、尿转铁蛋白(uTRF)、尿α1-微球蛋白(uα1-MG)、尿β2-微球蛋白(uβ2-MG)和尿视黄醇结合蛋白(uRBP)比较,差异均无统计学意义。当eGFR<90 mL/(min·1.73 m^(2))时,CKD组患者的血清肌酐(sCr)显著高于PE组,而PE组的sAlb远低于CKD组。PE组患者的24 h蛋白尿仍高于CKD组。PE组患者的uAlb显著高于CKD组,而PE组的uβ2-MG和uRBP显著低于CKD组;以eGFR=90 mL/(min·1.73 m^(2))为标准,PE组内eGFR≥该标准的孕妇,其sAlb高于eGFR<该标准的PE孕妇,但sCr、BUN、24 h蛋白尿、uAlb、uTRF和uα1-MG均低于eGFR<该标准的PE孕妇。在CKD组内,eGFR≥该标准的CKD孕妇,其sAlb高于eGFR<该标准的CKD孕妇,但sCr、BUN、24 h蛋白尿、uAlb、uTRF、uα1-MG、uβ2-MG和uRBP均低于eGFR<该标准的CKD孕妇。结论 随着eGFR水平的下降,PE和CKD孕妇的蛋白尿成分存在显著差异。PE中eGFR的下降与低蛋白血症有关。而uα1-MG、uβ2-MG和uRBP水平的升高与CKD孕妇eGFR下降和sCr升高有关。 Objective To explore the difference on the proteinuria components between pregnant women with declined estimated glomerular filtration rate(eGFR) in preeclampsia(PE) and chronic kidney disease(CKD). Methods An retrospective study was conducted among 328 pregnant women from July 2016 to December 2022. Results of the eGFR and proteinuria components were collected. Results With eGFR≥90 mLL/(min·1.73 m^(2)), serum albumin(sAlb) in CKD was higher than that in PE, while 24 h proteinuria in PE was higher than that in CKD. There was no significant difference on urinary microalbumin(uAlb), transferrin(TRF), α1-microglobulin(α1-MG), β2-microglobulin(β2-MG), and retinol-binding protein(RBP) between PE and CKD. With eGFR<90 mL/(min·1.73 m^(2)), serum creatine(sCr) in CKD was higher than that in PE,while sAlb in PE was lower than that in CKD. 24 h proteinuria in PE was still higher than that in CKD. UAlb in the PE was higher than in CKD, while uβ2-MG and uRBP in PE was significantly lower than in the CKD group. The standard eGFR value of 90 mLL/(min·1.73 m2) was utilized. In the PE group, sAlb levels were higher, while sCr, BUN, 24 h proteinuria, uAlb,uTRF and uα1-MG levels were lower in those with an eGFR greater than or equal to this standard compared to those with an eGFR less than this standard. Among the CKD group, sAlb levels were higher in pregnant women with CKD and an eGFR greater than or equal to this standard compared to those with an eGFR less than this standard. However, sCr, BUN, 24 h proteinuria, uAlb, uTRF, uα1-MG, uβ2-MG, and uRBP levels were lower in CKD group with an eGFR greater than or equal to this standard. Conclusion There was a significant difference in proteinuria components between PE and CKD pregnant women with the declined eGFR levels. The decline of eGFR and appearance of glomerular urine protein in PE is related to hypoproteinemia, while an elevated level of uα1-MG, uβ2-MG and uRBP indicates the decline of eGFR with elevated sCr in CKD.
作者 冯蜀欢 林建华 张羽 徐维维 庄旭 FENG Shuhuan;LIN Jianhua;ZHANG Yu;XU Weiwei;ZHUANG Xu(Department of Obstetrics and Gynecology,School of Medicine,Ren Ji Hospital,Shanghai Jiaotong University,Shanghai 200127,China;Ofice of Outpatient and Emergency,School of Medicine,Ren Ji Hospital,Shanghai Jiaotong University,Shanghai 200127,China)
出处 《中国优生与遗传杂志》 2024年第7期1379-1384,共6页 Chinese Journal of Birth Health & Heredity
基金 上海交通大学“交大之星”计划医工交叉研究基金(YG2021QN24) 国家卫健委医院管理研究所“医疗质量循证管理持续改进研究项目”(YLZLXZ23K008)。
关键词 子痫前期 妊娠合并慢性肾病 肾小球滤过率 蛋白尿成分 preeclampsia pregnancies complicated with chronic kidney disease eGFR proteinuria components
  • 相关文献

参考文献2

二级参考文献22

  • 1Johnson MP, Brennecke SP, East CE, Goring HH, Kent JW Jr, Dyer TD, et al. Genome-wide association scan identifies a risk locus for preeclampsia on 2ql4, near the inhibin, beta B gene. PLoS One 2012;7:e33666.
  • 2Ni S, Zhang Y, Deng Y, Gong Y, Huang J, Bai Y, et al. AGT M235T polymorphism contributes to risk of preeclampsia: Evidence from a meta-analysis. J Renin Angiotensin Aldosterone Syst 2012; 13:379-86.
  • 3Muniz L, Luizon MR, Palei AC, Lacchini R, Duarte G, Cavalli RC, et al. eNOS tag SNP haplotypes in hypertensive disorders of pregnancy. DNA Cell Biol 2012;31:1665-70.
  • 4Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; SOGC Hypertension Guideline Committee. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: Executive summary. J Obstet Gynaecol Can 2014;36:575-6.
  • 5Amaral LM, Cunningham MW Jr, Cornelius DC, LaMarca B. Preeclampsia: Long-term consequences for vascular health. Vase Health Risk Manag 2015;11:403-15.
  • 6Valenzuela FJ, Perez-Sepulveda A, Torres MJ, Correa P, Repetto GM, Illanes SE. Pathogenesis of preeclampsia: The genetic component. J Pregnancy 2012;2012:632732.
  • 7European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM), Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147-97.
  • 8American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122:1122-31.
  • 9Kintiraki E, Papakatsika S, Kotronis G, Goulis DG, Kotsis V. Pregnancy-induced hypertension. Hormones (Athens) 2015;14:211-23.
  • 10Dekker GA. Management of preeclampsia. Pregnancy Hypertens 2014;4:246-7.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部